Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin

Nicola Torrance, Blair H Smith, Margaret C Watson, Michael I Bennett

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

BACKGROUND: Neuropathic pain is widely recognized as one of the most difficult pain syndromes to treat and presents a significant challenge for pain clinicians and GPs.METHODS: The Self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire, recently validated for identifying pain of predominantly neuropathic origin (POPNO), was sent to 6000 adults identified from general practices in the UK. The questionnaire also contained items about chronic pain identification, medications and treatments received for pain and the pain relief these provided.RESULTS: In total, 1420/3002 (48%) of respondents indicated that they suffered with any chronic pain. These were further categorized as those with chronic pain who were S-LANSS negative ['chronic pain (non-POPNO)' group, n = 1179] and those with chronic pain who were S-LANSS positive, indicating the presence of POPNO ('chronic POPNO' group, n = 241). Questions relating to treatments and medications were completed by 88% of the respondents (1244/1420). The chronic POPNO group was more likely to receive multiple pain medications (37% versus 21% took two or more pain medications, P <0.001) and stronger painkillers [e.g. opioids odds ratio 1.94; 95% confidence interval 1.10, 3.42]. Despite this, they reported less effective pain relief than the non-POPNO chronic pain group.CONCLUSION: Patients in primary care reporting chronic pain were found generally to obtain incomplete relief from their medication with chronic POPNO patients reporting less relief. It is important that patients with any chronic pain are identified and managed appropriately according to their distinct treatment needs.
LanguageEnglish
Pages481-485
Number of pages5
JournalFamily Practice
Volume24
Issue number5
DOIs
Publication statusPublished - Oct 2007

Fingerprint

Chronic Pain
Primary Health Care
Pain
Symptom Assessment
Neuralgia
Therapeutics
Signs and Symptoms
General Practice
Opioid Analgesics
Odds Ratio
Confidence Intervals
Surveys and Questionnaires

Keywords

  • adult
  • aged
  • analgesics
  • anti-inflammatory agents, non-steroidal
  • anticonvulsants
  • antidepressive agents
  • central nervous system agents
  • chronic diseases
  • female
  • Great Britain
  • health surveys
  • humans
  • male
  • middle aged
  • neuralgia
  • outcome and process assessment (health care)
  • pain measurement
  • parasympatholytics
  • physical therapy modalities
  • prevalence
  • primary health care
  • severity of illness index
  • urban health

Cite this

Torrance, Nicola ; Smith, Blair H ; Watson, Margaret C ; Bennett, Michael I. / Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. In: Family Practice. 2007 ; Vol. 24, No. 5. pp. 481-485.
@article{526731df799e4c378630d59e7a76b91a,
title = "Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin",
abstract = "BACKGROUND: Neuropathic pain is widely recognized as one of the most difficult pain syndromes to treat and presents a significant challenge for pain clinicians and GPs.METHODS: The Self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire, recently validated for identifying pain of predominantly neuropathic origin (POPNO), was sent to 6000 adults identified from general practices in the UK. The questionnaire also contained items about chronic pain identification, medications and treatments received for pain and the pain relief these provided.RESULTS: In total, 1420/3002 (48{\%}) of respondents indicated that they suffered with any chronic pain. These were further categorized as those with chronic pain who were S-LANSS negative ['chronic pain (non-POPNO)' group, n = 1179] and those with chronic pain who were S-LANSS positive, indicating the presence of POPNO ('chronic POPNO' group, n = 241). Questions relating to treatments and medications were completed by 88{\%} of the respondents (1244/1420). The chronic POPNO group was more likely to receive multiple pain medications (37{\%} versus 21{\%} took two or more pain medications, P <0.001) and stronger painkillers [e.g. opioids odds ratio 1.94; 95{\%} confidence interval 1.10, 3.42]. Despite this, they reported less effective pain relief than the non-POPNO chronic pain group.CONCLUSION: Patients in primary care reporting chronic pain were found generally to obtain incomplete relief from their medication with chronic POPNO patients reporting less relief. It is important that patients with any chronic pain are identified and managed appropriately according to their distinct treatment needs.",
keywords = "adult, aged, analgesics, anti-inflammatory agents, non-steroidal, anticonvulsants, antidepressive agents, central nervous system agents, chronic diseases, female, Great Britain, health surveys, humans, male, middle aged, neuralgia, outcome and process assessment (health care), pain measurement, parasympatholytics, physical therapy modalities, prevalence, primary health care, severity of illness index, urban health",
author = "Nicola Torrance and Smith, {Blair H} and Watson, {Margaret C} and Bennett, {Michael I}",
year = "2007",
month = "10",
doi = "10.1093/fampra/cmm042",
language = "English",
volume = "24",
pages = "481--485",
journal = "Family Practice",
issn = "0263-2136",
number = "5",

}

Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. / Torrance, Nicola; Smith, Blair H; Watson, Margaret C; Bennett, Michael I.

In: Family Practice, Vol. 24, No. 5, 10.2007, p. 481-485.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin

AU - Torrance, Nicola

AU - Smith, Blair H

AU - Watson, Margaret C

AU - Bennett, Michael I

PY - 2007/10

Y1 - 2007/10

N2 - BACKGROUND: Neuropathic pain is widely recognized as one of the most difficult pain syndromes to treat and presents a significant challenge for pain clinicians and GPs.METHODS: The Self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire, recently validated for identifying pain of predominantly neuropathic origin (POPNO), was sent to 6000 adults identified from general practices in the UK. The questionnaire also contained items about chronic pain identification, medications and treatments received for pain and the pain relief these provided.RESULTS: In total, 1420/3002 (48%) of respondents indicated that they suffered with any chronic pain. These were further categorized as those with chronic pain who were S-LANSS negative ['chronic pain (non-POPNO)' group, n = 1179] and those with chronic pain who were S-LANSS positive, indicating the presence of POPNO ('chronic POPNO' group, n = 241). Questions relating to treatments and medications were completed by 88% of the respondents (1244/1420). The chronic POPNO group was more likely to receive multiple pain medications (37% versus 21% took two or more pain medications, P <0.001) and stronger painkillers [e.g. opioids odds ratio 1.94; 95% confidence interval 1.10, 3.42]. Despite this, they reported less effective pain relief than the non-POPNO chronic pain group.CONCLUSION: Patients in primary care reporting chronic pain were found generally to obtain incomplete relief from their medication with chronic POPNO patients reporting less relief. It is important that patients with any chronic pain are identified and managed appropriately according to their distinct treatment needs.

AB - BACKGROUND: Neuropathic pain is widely recognized as one of the most difficult pain syndromes to treat and presents a significant challenge for pain clinicians and GPs.METHODS: The Self-complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire, recently validated for identifying pain of predominantly neuropathic origin (POPNO), was sent to 6000 adults identified from general practices in the UK. The questionnaire also contained items about chronic pain identification, medications and treatments received for pain and the pain relief these provided.RESULTS: In total, 1420/3002 (48%) of respondents indicated that they suffered with any chronic pain. These were further categorized as those with chronic pain who were S-LANSS negative ['chronic pain (non-POPNO)' group, n = 1179] and those with chronic pain who were S-LANSS positive, indicating the presence of POPNO ('chronic POPNO' group, n = 241). Questions relating to treatments and medications were completed by 88% of the respondents (1244/1420). The chronic POPNO group was more likely to receive multiple pain medications (37% versus 21% took two or more pain medications, P <0.001) and stronger painkillers [e.g. opioids odds ratio 1.94; 95% confidence interval 1.10, 3.42]. Despite this, they reported less effective pain relief than the non-POPNO chronic pain group.CONCLUSION: Patients in primary care reporting chronic pain were found generally to obtain incomplete relief from their medication with chronic POPNO patients reporting less relief. It is important that patients with any chronic pain are identified and managed appropriately according to their distinct treatment needs.

KW - adult

KW - aged

KW - analgesics

KW - anti-inflammatory agents, non-steroidal

KW - anticonvulsants

KW - antidepressive agents

KW - central nervous system agents

KW - chronic diseases

KW - female

KW - Great Britain

KW - health surveys

KW - humans

KW - male

KW - middle aged

KW - neuralgia

KW - outcome and process assessment (health care)

KW - pain measurement

KW - parasympatholytics

KW - physical therapy modalities

KW - prevalence

KW - primary health care

KW - severity of illness index

KW - urban health

U2 - 10.1093/fampra/cmm042

DO - 10.1093/fampra/cmm042

M3 - Article

VL - 24

SP - 481

EP - 485

JO - Family Practice

T2 - Family Practice

JF - Family Practice

SN - 0263-2136

IS - 5

ER -